University of Central Lancashire, Preston, UK
Blackpool Victoria Hospital, Blackpool, UK.
BMJ Open Gastroenterol. 2024 Sep 12;11(1):e001483. doi: 10.1136/bmjgast-2024-001483.
Chronic pain in inflammatory bowel disease (IBD) is common and detrimental to quality of life. Recent Cochrane reviews identified a multitude of randomised controlled trial interventions, but the certainty of the findings is low or very low. We set out to reach a patient and professional co-produced Delphi consensus on treatment priorities, key outcomes and propose a model for understanding our findings.
An online survey was co-produced with Crohn's and Colitis UK and sent to patients and healthcare professionals in two phases, for prioritisation of treatments and outcome measures. Phase three consisted of four online group interviews, where patients and healthcare professionals discussed the rationale of their choices. Transcripts were combined with the free text data from the Delphi surveys and analysed through a three-phase qualitative technique.
The phase 1 survey was completed by 128 participants (73 patients, 3 carers and 53 health professionals). Diet was the top priority for both patients (n=26/73, 36.1%) and healthcare professionals (n=29/52, 56.9%). Phase 2 was completed by 68 participants. FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet, stress management therapy and relaxation therapy were the top three consensus priorities. Phase 3 group interviews were attended by 13 patients and 5 healthcare professionals. Key themes included: The patient as an individual, beliefs and experiences, disease activity influencing therapy choice, accessibility barriers and quality of life.
Low FODMAP diet, followed by psychological therapies were the highest-rated research priorities for healthcare professionals and patients. Funding bodies and researchers should consider these findings, alongside the model for understanding our findings, when making research decisions.
炎症性肠病(IBD)的慢性疼痛很常见,且对生活质量有害。最近的 Cochrane 综述确定了许多随机对照试验干预措施,但研究结果的确定性较低或极低。我们旨在达成患者和专业人员共同制定的 Delphi 共识,确定治疗重点、关键结局,并提出一种理解研究结果的模型。
一项在线调查由克罗恩病和结肠炎英国(Crohn's and Colitis UK)共同制作,并分两个阶段发送给患者和医疗保健专业人员,用于治疗方案和结局指标的优先排序。第三阶段包括四项在线小组访谈,患者和医疗保健专业人员在访谈中讨论其选择的理由。对访谈的记录和 Delphi 调查的自由文本数据进行了综合分析,采用了一个三阶段的定性技术。
第 1 阶段的调查由 128 名参与者(73 名患者、3 名照顾者和 53 名医疗保健专业人员)完成。饮食是患者(73 名患者中有 26 名,占 36.1%)和医疗保健专业人员(52 名医疗保健专业人员中有 29 名,占 56.9%)的首要关注。第 2 阶段有 68 名参与者完成。FODMAP(可发酵寡糖、二糖、单糖和多元醇)饮食、压力管理疗法和放松疗法是前三个共识优先事项。第 3 阶段的小组访谈有 13 名患者和 5 名医疗保健专业人员参加。主要主题包括:个体患者、信念和经验、疾病活动影响治疗选择、可及性障碍和生活质量。
低 FODMAP 饮食,其次是心理治疗,是医疗保健专业人员和患者认为最重要的研究重点。在做出研究决策时,资助机构和研究人员应考虑这些发现,以及理解研究结果的模型。